Author

D. D'Andrea

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:behavioral assay· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Bhakta· 1 shared A. Carracedo· 1 shared A. Clear· 1 shared A. Orlova· 1 shared A. Q. Xu· 1 shared A. Tracz· 1 shared A. Varady· 1 shared A. Willbanks· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bhakta

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintNov 13, 2023

Gait speed is a biomarker of cancer-associated cachexia decline and recovery

I. Roy, B. Binder-Markey, D. Sychowski…·R. L. Lieber

This paper identifies gait speed as a more reliable biomarker of cancer-associated cachexia decline and recovery compared to grip strength, using both animal models and human patient data.

DOI 10.1101/2023.11.13.566852

mousebehavioral assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 25, 2022

STAT3 restricts prostate cancer metastasis and antiandrogen resistance by controlling LKB1/CREB signaling pathway

J. Pencik, C. Philippe, M. Schlederer…·C. McKinney

This study identifies STAT3's role in restricting prostate cancer metastasis and antiandrogen resistance by regulating the LKB1/CREB signaling pathway in mouse models and human patients.

DOI 10.1101/2022.08.25.504915

mousehuman

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 12, 2020

Co-activation of NF-κB and MYC renders cancer cells addicted to IL6 for survival and phenotypic stability

R. Barbosa, A. Q. Xu, D. D'Andrea…·D. P. Calado

This paper shows that co-activation of NF-κB and MYC in cancer cells makes them dependent on IL6 for survival and leads to a poorly-differentiated state similar to human plasmablastic lymphoma and t(8;14)[MYC-IGH] multiple myeloma.

DOI 10.1101/2020.04.12.038414

mouseexperimental assay

𝕏 PostBluesky